These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9074692)

  • 21. [Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke].
    Minerva Med; 2003 Apr; 94(2):XIII-IV. PubMed ID: 12916522
    [No Abstract]   [Full Text] [Related]  

  • 22. Effective platelet inhibition by aspirin and clopidogrel: where are we now?
    Tousoulis D; Briasoulis A; Dhamrait SS; Antoniades C; Stefanadis C
    Heart; 2009 May; 95(10):850-8. PubMed ID: 19401288
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term antithrombotic treatment in coronary disease].
    Hodara M; Samama M
    J Mal Vasc; 1983; 8(1):28-32. PubMed ID: 6405004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic agents in coronary artery disease.
    Cairns JA; Théroux P; Lewis HD; Ezekowitz M; Meade TW
    Chest; 2001 Jan; 119(1 Suppl):228S-252S. PubMed ID: 11157652
    [No Abstract]   [Full Text] [Related]  

  • 25. Warfarin, aspirin, or both after myocardial infarction.
    Amit G; Ilia R; Zahger D
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530435
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiplatelet therapy for ischemic heart disease in the elderly.
    Frishman WH; Miller KP
    Geriatrics; 1988 Dec; 43 Suppl():46-56. PubMed ID: 3056785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
    Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
    Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anticoagulants and antiaggregants in ischemic heart disease].
    Motolese M
    G Ital Cardiol; 1990 Aug; 20(8):746-57. PubMed ID: 2272424
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long term aspirin in stable coronary disease with an indication for anticoagulation: is it reasonable?].
    Lister K; Louis Simonet M
    Rev Med Suisse; 2015 Oct; 11(490):1904, 1906-8. PubMed ID: 26665660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombotic therapy in coronary artery disease.
    Genton E
    Adv Cardiol; 1980; 27():93-8. PubMed ID: 7446296
    [No Abstract]   [Full Text] [Related]  

  • 32. Antithrombotic therapy after myocardial infarction.
    Becker RC
    N Engl J Med; 2002 Sep; 347(13):1019-22. PubMed ID: 12324559
    [No Abstract]   [Full Text] [Related]  

  • 33. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Armstrong EC
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572582
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anticoagulation and antiaggregation in cardiac patients].
    Meyer BJ
    Ther Umsch; 2003 Jan; 60(1):27-32. PubMed ID: 12638475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
    Jackson G
    Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
    [No Abstract]   [Full Text] [Related]  

  • 36. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study.
    Gurbuz AT; Zia AA; Vuran AC; Cui H; Aytac A
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):190-5. PubMed ID: 16388957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eptifibatide in acute coronary syndromes.
    Segal J
    N Engl J Med; 1999 Jan; 340(1):60; author reply 61. PubMed ID: 9882214
    [No Abstract]   [Full Text] [Related]  

  • 39. Warfarin, aspirin, or both after myocardial infarction.
    Pullicino P; Thompson JL
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12529470
    [No Abstract]   [Full Text] [Related]  

  • 40. [The new frontier of antithrombotic therapy: ASA + warfarin, the ideal solution?].
    Cimminiello C; Soncini M; Casazza F
    G Ital Cardiol; 1995 Sep; 25(9):1187-93. PubMed ID: 8529856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.